Isatuximab, Bendamustine, and Prednisone in Refractory Multiple Myeloma

NCT04083898 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Decision made to not move forward with Phase II portion of trial

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: Isatuximab
DRUG: Bendamustine
DRUG: Prednisone

Sponsor

Washington University School of Medicine

Collaborators

[object Object]